Virtual Practice Managing Immune-Related Adverse Events (irAEs) in Simulated Scenarios
Released On
July 13, 2023
Expires On
July 13, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Hematology-Oncology, Pharmacy
Topic(s)
Cancer Care, irAEs, Oncology
This activity is provided by HorizonCME
This activity is supported by an educational grant from Merck Sharp & Dohme LLC.
Credit Available
- Physicians — maximum of 0.50 AMA PRA Category 1 Credit(s)™
- Nurse Practitioners & Nurses — 0.50 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
Pharmacists, specialty nurses in cancer care, and advanced practice providers, specifically nurse practitioners and physician assistants in cancer care.
Program Overview
In this targeted AliveSim format, learners will be immersed in two scenarios to drive changes in clinical decision-making with irAEs. At the end of the activity, the learner will have completed two hands-on clinical experiences where they learn how to optimally manage irAEs with corrective mentoring from a virtual oncology expert. The design involves two irAE management scenarios that are similar and share the same clinical decision. The optimal choices in the decision will be different in each scenario allowing learners to recognize the optimal management patterns experts use.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review both common and rare adverse events associated with immune checkpoint inhibitors (ICIs).
- Apply guideline recommended strategies to proactively identify, monitor, and manage immune-related adverse events (irAEs).
- Discuss the importance of the APP role in the collaborative approach for the identification and management of irAEs.
Faculty
Marianne Davies DNP, ACNP, AOCNP, FAAN
Associate Professor
Yale University
Yale School of Nursing
Oncology Nurse Practitioner-Thoracic & Solid Tumor
Senior Advanced Practice Provider II
Smilow Cancer Hospital at Yale-New Haven
Yale Comprehensive Cancer Center
New Haven, CT
Ms. Davies has no relevant financial information to disclose.
Accreditation Statement
Horizon CME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Physician Credit Designation Statement
Horizon CME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria.
Nurse Credit Designation
This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.50 contact hours.
Disclosures of Conflicts of Interest
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.
All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Participants must review all activity information, including the pre-test, learning objectives, faculty disclosure information, simulation scenario(s) and post-activity evaluation.
- To view the first simulation scenario, launch the simulation from the link provided using a PC, Mac, Tablet, or Phone with a 4G or higher internet connection.
- Interact appropriately to satisfy each objective to unlock the next objective and view the next simulation scenario.
- The simulation will track your progress until all scenario objectives are complete.
- Exit the simulation at any time, and your progress will be saved so you can return to finish at a later time.
- Complete both scenarios to qualify for 0.5 credits. Click or tap “Credit” to determine your CE credit status.
- Upon successful completion of the evaluation, you can download/print a certificate of credit immediately via the browser. The last day to access the evaluation is July 13, 2024 at 11:59pm (Pacific Standard Time).
Disclosure of Unlabeled Use
Horizon CME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact Horizon CME at (503) 659-5558 or at [email protected].
Copyright Statement
This CME simulation activity is licensed to Horizon. Copyright © 2023 Syandus Inc and Horizon. All rights reserved. No part of this simulation activity may be reproduced without written permission from Horizon and Syandus Inc.